Immunohistochemical status of the p53 protein and Ki-67 antigen using biopsied specimens can predict a sensitivity to neoadjuvant therapy in patients with esophageal cancer. - Concepedia

Concepedia

Publication | Closed Access

Immunohistochemical status of the p53 protein and Ki-67 antigen using biopsied specimens can predict a sensitivity to neoadjuvant therapy in patients with esophageal cancer.

39

Citations

0

References

2000

Year

Kaoru Kitamura, Hiroshi Saeki, Hidetoshi Kawaguchi, Koshi Araki, Shinji Ohno, Hiroyuki Kuwano, Yoshihiko Maehara, Keizō Sugimachi

Abstract

An immunohistochemical analysis of p53 and the Ki-67 labeling percentage using biopsied specimens was thus found to effectively predict the efficacy of neoadjuvant therapies in patients with esophageal cancer.